Phase 2 Macular Degeneration Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People aged 16 years or older, of any gender
• People who are able to attend all scheduled visits and complete all required study assessments
• People who have been diagnosed with Stargardt Disease, confirmed through genetic testing
• People whose vision (with best possible correction) in both eyes meets the specific levels required by the study
• People whose eye scans show that certain layers of cells at the back of the eye are still present, as confirmed by a specialist imaging centre
• People who are in generally good health with adequately functioning organs

Who may not be able to join:

• People who have taken part in a clinical trial involving an experimental drug, agent, or therapy (for the eyes or otherwise) within the past six months
• People currently enrolled in another interventional clinical eye study
• People who have previously received any form of gene therapy (for the eyes or elsewhere), a retinal implant, or a cell-based eye treatment
• People who have pre-existing eye conditions in either eye that could interfere with the planned treatment or make it harder to interpret study results
• People who are known to respond to steroid medications by developing increased eye pressure that cannot be adequately managed with eye-drop pressure-lowering medications
• People with certain serious systemic (whole-body) illnesses where the disease itself, or its treatment, could affect eye or brain function — for example, those who have received radiation treatment near the eye area, or have a blood cancer affecting the optic nerve
• People with immune system problems, including conditions that weaken the immune system or those currently taking medications that suppress the immune system
• People who have had cataract surgery, other eye or refractive surgery, or injections in or around either eye within the four months before the screening visit
• People who have previously had a vitrectomy (a type of eye surgery) or who are missing the natural lens in the eye being studied
• People with a known sensitivity or allergy to any component of the study treatment, or to any medications planned for use around the time of the procedure (for example, povidone-iodine)
• People who have a known reason they cannot take the steroid preventive medication required by the study
• People who are currently pregnant or breastfeeding
• People with any other condition that would prevent them from completing all follow-up visits during the study

Important: Always verify eligibility with the trial site directly before applying.